An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, the Press Trust of India reported on Thursday.
Prakash Kumar Singh, director (government and regulatory affairs) at Serum Institute of India (SII) had recently written a letter to the Drugs Controller General of India (DCGI) for approval of Covovax heterologous booster dose for those aged 18 years and above in view of escalating COVID-19 pandemic situation in some countries, the official sources said.
"The subject expert committee (SEC) of the CDSCO on Wednesday deliberated on the issue and recommended for market authorisation of Covid jab Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin," an official source said.
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and also in children aged 7-11 years on June 28, 2022 subject to certain conditions.
Covovax is manufactured through technology transfer from Novavax. It has been approved by the European Medicines Agency for conditional marketing authorization. It was granted an emergency-use listing by the World Health Organization (WHO) on December 17, 2021.
In August 2020, US-based vaccine maker Novavax Inc. announced a licence agreement with SII for the development and commercialization of NVX-CoV2373, its COVID-19 vaccine candidate in India and low-and-middle-income countries.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Featured Video Of The Day
NIRF Rankings 2024: IIT Madras Ranks Number 1 For The Sixth Year
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal "Great Potential To...": Adar Poonawalla's Tweet On 1st Batch Of Covovax "Covovax Trials Finally Begin In India," Tweets Adar Poonawalla 150 mg Semen In Kolkata Doctor's Body, Suspect Gang-Rape: Parents To Court "Reclaim The Night": Women Seek Justice In Kolkata Doctor Rape-Murder Case "Want To Ask Congress...": Mamata Banerjee Snaps At Ally In Rape-Murder Case 8 Of Family Hospitalised After Consuming Wild Mushroom In Jharkhand: Cops US' UCLA Must Protect Jewish Students' Access To Campus, Judge Rules For 1st Time, Tricolour To Be Hoisted In Villages Of This Maoist-Hit Region Track Latest News Live on NDTV.com and get news updates from India and around the world.